Novartis AG (NOVN)

82.32
-0.18(-0.22%)
  • Volume:
    3,668,109
  • Bid/Ask:
    82.31/82.32
  • Day's Range:
    81.87 - 82.76
  • Type:Equity
  • Market:Switzerland
  • ISIN:CH0012005267
  • S/N:1200526

NOVN Comments

What is your sentiment on Novartis AG?
or
Market is currently closed. Voting is open during market hours.

All Comments

(2)
  • Novartis is trading at a value last seen in 2018; the funds released from a Sandoz divestment need to be directed towards further patient innovation from this Swiss Pharma major …
    0
    • Hi Guys, I have been invested in Novartis for 5 years and have closely followed the pharmaceutical industry for years. I have been very disappointed with the returns and am looking to transfer my portfolio into riskier assets. Upon research, I think I may have found an even better pharmaceutical company going by the name of SpectrumX. SpectrumX are leaders in patented shielded HOCL formulations that have numerous applications in medical/pharma fields. They have also undergone 2 clinical trials for Covid-19 treatment (apparently not factored into the company valuation.) To me this company seems to be on track for high growth after the IPO, however I may be getting lost in the hype. Would love to hear people's thoughts on the stock as I am keen to invest early.
      0
      THE FOREX TRADING GUIDE BY

      7 eBooks for free

      A great tool for anyone who wants to learn to trade the financial markets. Whether a novice trader or an experienced trader.

      Currency Explorer

        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.